Pilot Study on the Use of iENTER, iCONSENT and iPARTICIPATE E-tools

Launched by FONDAZIONE IRCCS ISTITUTO NAZIONALE DEI TUMORI, MILANO · Mar 12, 2024

Keywords

ClinConnect Summary

This clinical trial is looking at new online tools designed to help cancer patients participate in a special type of treatment called precision oncology. The trial, part of a larger study called the Basket of Basket (BoB) study, aims to provide personalized treatment based on each patient’s unique cancer profile. The three tools being tested are: iENTER, which is an informative website for potential participants and their caregivers; iCONSENT, a web app that helps manage the consent process for joining the trial; and iPARTICIPATE, which allows patients to keep track of their appointments and medications, and communicate with their healthcare team.

To be eligible for this trial, you need to be a cancer patient or an informal caregiver who can use the internet and fill out a simple online form. Unfortunately, if someone has noticeable issues with memory or understanding, they may not be able to participate. Participants will have the chance to try out these tools and provide feedback on how they work, helping to improve them for future patients. This is an exciting opportunity to be part of a study that could change how cancer treatments are delivered.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Cancer patients, or their informal caregivers, candidates to precision oncology trials. Patients or caregivers able to surf the internet and to fill in a simple online form.
• Exclusion Criteria:
• • People with clinically evident cognitive impairment.